These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 26957517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.
    Arbel Y, Klempfner R, Erez A, Goldenberg I, Benzekry S, Shlomo N, Fisman EZ, Tenenbaum A, BIP Study Group.
    Cardiovasc Diabetol; 2016 Jan 22; 15():11. PubMed ID: 26794137
    [Abstract] [Full Text] [Related]

  • 3. Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry.
    Haim M, Benderly M, Brunner D, Behar S, Graff E, Reicher-Reiss H, Goldbourt U.
    Circulation; 1999 Aug 03; 100(5):475-82. PubMed ID: 10430760
    [Abstract] [Full Text] [Related]

  • 4. Decrease in triglyceride level by bezafibrate is related to reduction of recurrent coronary events: a Bezafibrate Infarction Prevention substudy.
    Haim M, Benderly M, Boyko V, Goldenberg I, Tanne D, Battler A, Goldbourt U, Behar S, Bezafibrate Infarction Prevention (BIP) Study Group.
    Coron Artery Dis; 2006 Aug 03; 17(5):455-61. PubMed ID: 16845254
    [Abstract] [Full Text] [Related]

  • 5. Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.
    Christian JB, Arondekar B, Buysman EK, Jacobson TA, Snipes RG, Horwitz RI.
    Am J Med; 2014 Jan 03; 127(1):36-44.e1. PubMed ID: 24384100
    [Abstract] [Full Text] [Related]

  • 6. Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease.
    Younis A, Younis A, Tzur B, Peled Y, Shlomo N, Goldenberg I, Fisman EZ, Tenenbaum A, Klempfner R.
    Cardiovasc Diabetol; 2016 Oct 28; 15(1):149. PubMed ID: 27793156
    [Abstract] [Full Text] [Related]

  • 7. Association of elevated triglycerides and acute myocardial infarction in young Hispanics.
    Essilfie G, Shavelle DM, Tun H, Platt K, Kobayashi R, Mehra A, Matthews RV, Clavijo L, Gaglia MA.
    Cardiovasc Revasc Med; 2016 Dec 28; 17(8):510-514. PubMed ID: 27432210
    [Abstract] [Full Text] [Related]

  • 8. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor.
    Tanne D, Koren-Morag N, Graff E, Goldbourt U.
    Circulation; 2001 Dec 11; 104(24):2892-7. PubMed ID: 11739302
    [Abstract] [Full Text] [Related]

  • 9. Triglycerides and coronary heart disease: implications of recent clinical trials.
    Rubins HB.
    J Cardiovasc Risk; 2000 Oct 11; 7(5):339-45. PubMed ID: 11143764
    [Abstract] [Full Text] [Related]

  • 10. Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
    Brodov Y, Behar S, Boyko V, Chouraqui P.
    Am J Cardiol; 2010 Dec 15; 106(12):1717-20. PubMed ID: 21126615
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
    Fruchart JC, Duriez P.
    Drugs Today (Barc); 2006 Jan 15; 42(1):39-64. PubMed ID: 16511610
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Association of Body Mass Index and 20-Year All-Cause Mortality Among Patients With Stable Coronary Artery Disease.
    Younis A, Younis A, Goldkorn R, Goldenberg I, Peled Y, Tzur B, Klempfner R.
    Heart Lung Circ; 2019 May 15; 28(5):719-726. PubMed ID: 29581037
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.